Morningstar, Inc. - November 4, 2025
3 Stocks to Sell and 3 Stocks to Buy in November
Plus: Growth Stocks Can Be Great, But They Aren’t the Only Road...
 Morning DigestNovember 4, 2025 David Sekera, Susan Dziubinski Plus, our take on the quarterly results from technology heavyweights. 
ADVERTISEMENT  Editor's Picks  Rather than chase hares, one could instead buy turtles. John Rekenthaler  Plus: Large-cap stocks, interest rates, AI and emerging markets. Dan Kemp  Market trends, top-rated picks, and analyst insights on actively managed exchange-traded funds. Margaret Giles, Tori Brovet  How to balance the tax and investment considerations. Christine Benz Investing Insights More than 10 strategies will distribute at least 25% in capital gains. Stephen Welch Welltower and Barclays are among the stocks rated as expensive. Bella Albrecht Meta and UnitedHealth are among the stocks that fell into undervalued territory. Bella Albrecht AMD and Micron rank among the best stocks in October 2025, while the worst include Fiserv and F5. Bella Albrecht With its valuation reaching nosebleed levels, here’s what we think of Palantir stock. Mark Giarelli Weigh the pros and cons before taking the financial leap, and learn how to manage debt together. Jess Bebel New Stock Analyst Reports Rocket (RKT) reported decent third-quarter results, with adjusted net revenue rising to $1.78 billion from $1.32 billion last year. Adjusted EPS came in at $0.07 compared with $0.08 last year, due to higher expenses and interest costs from the acquisitions of Redfin and Mr. Cooper. Results were in line with our expectations for Rocket as our projections call for a modest recovery in mortgage origination volume in 2025. That said, origination volume is still low industrywide due to high rates and affordability issues. New Fund Analyst Reports PIMCO Investment Grade Credit Bond A's (PBDAX) investment-grade credit strategy benefits from the skill of its veteran lead manager, the support of an impressive group of corporate-bond specialists, and a versatile process that draws on the firm's robust macroeconomic and fundamental research. The Tools You Need to Invest Like an Analyst Stay connected:
|
